Changlin Zhu

Title: Changlin Zhu: Innovator in Vaccine Technology

Introduction

Changlin Zhu is a prominent inventor based in Changchun, China. He has made significant contributions to the field of vaccine technology, particularly in the development of innovative compositions for live attenuated influenza vaccines. His work is characterized by a focus on enhancing vaccine efficacy and safety.

Latest Patents

Changlin Zhu holds a patent for a "Non-gelatin vaccine protectant composition and live attenuated influenza vaccine." This invention provides a composition for use as a protectant for a live attenuated influenza virus vaccine. The composition includes human serum albumin at concentrations of 1.0-15.0 g/L, sugar at 15.0-95.0 g/L, and sodium glutamate at 0.5-15.0 g/L. The process for preparing the vaccine involves dissolving these components in a pH buffer solution, adjusting the pH, performing filtration sterilization, and adding virus stock. This innovative vaccine can be administered as an injection or nasal spray.

Career Highlights

Changlin Zhu is associated with Changchun Bcht Biotechnology Co., where he continues to advance his research and development efforts. His work has been instrumental in the field of biotechnology, particularly in vaccine formulation and delivery systems.

Collaborations

Changlin Zhu collaborates with notable colleagues, including Zhenwei Shen and Xiaohui Chen. Their combined expertise contributes to the ongoing advancements in vaccine technology and biotechnology.

Conclusion

Changlin Zhu's innovative work in vaccine technology exemplifies the importance of research and development in public health. His contributions, particularly in the formulation of live attenuated influenza vaccines, highlight the potential for improved vaccine efficacy and safety.